2010Unpublished venueRequires access

Intervention effect of probucol on islet function in type 2 diabetes rats

Liang Yu-zhe

Open publisher page 0 citations

Abstract

Objective To investigate the effect of antioxidant probucol on oxidative stress and secretory function of islet in type 2 diabetes rats. Methods Twenty-four rats were randomly divided into three groups:normal control group(group A) ,diabetic group(group B) and probucol-treated diabetic group(group C) ,8 in each. Rats in group C were treated with probucol for one month [500 mg/(kg/d) ,twice per day]. High-fat and high-sugar diets with a low dose injection of streptozotocin were performed in rats to establish type 2 diabetic models. The methods of glucose oxidase,enzymatic end-point and radioimmunoassay were repeatedly used to test the levels of fasting blood glucose(FBG) ,postprandial blood glucose(PBG) ,triglyceride(TG) ,total cholesterol(T-ch) and fasting insulin(FINS) . Pancreatic tissues were homogenized to test the content of malondialdehyde(MDA) ,nitric oxide(NO) ,superoxide dismutase(SOD) and glutathione peroxidase(GSH-Px) . Immunohistochemical method was used to detect the insulin expression. Results Compared with rats in the group A,the levels of MDA,NO and FINS were higher,while the levels of SOD,GSH-Px and insulin expression were lower in the group B(all P0.05) . After treated with probucol,compared with the group B,the levels of MDA,NO were lower,while the levels of SOD,GSH-Px and insulin expression were higher in the group C(all P0.05) . Conclusion Probucol can preserve pancreatic islet against damage from oxidative stress and improve the endocrine function of islet cells in type 2 diabetic rats.

About this research paper

What this paper is about

Objective To investigate the effect of antioxidant probucol on oxidative stress and secretory function of islet in type 2 diabetes rats. Methods Twenty-four rats were randomly divided into three groups:normal control group(group A) ,diabetic group(group B) and probucol-treated diabetic group(group C) ,8 in each. Rats in group C were treated with probucol for one month [500 mg/(kg/d) ,twice per day]. High-fat and high-sugar diets with a low dose injection of streptozotocin were performed in rats to establish type 2 diabetic models. The methods of glucose oxidase,enzymatic end-point and radioimmunoassay were repeatedly used to test the levels of fasting blood glucose(FBG) ,postprandial blood glucose(PBG) ,triglyceride(TG) ,total cholesterol(T-ch) and fasting insulin(FINS) . Pancreatic tissues were homogenized to test the content of malondialdehyde(MDA) ,nitric oxide(NO) ,superoxide dismutase(SOD) and glutathione peroxidase(GSH-Px) . Immunohistochemical method was used to detect the insulin expression. Results Compared with rats in the group A,the levels of MDA,NO and FINS were higher,while the levels of SOD,GSH-Px and insulin expression were lower in the group B(all P0.05) . After treated with probucol,compared with the group B,the levels of MDA,NO were lower,while the levels of SOD,GSH-Px and insulin expression were higher in the group C(all P0.05) . Conclusion Probucol can preserve pancreatic islet against damage from oxidative stress and improve the endocrine function of islet cells in type 2 diabetic rats.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of antioxidant probucol on oxidative stress and secretory function of islet in type 2 diabetes rats. Methods Twenty-four rats were randomly divided into three groups:normal control group(group A) ,diabetic group(group B) and probucol-treated diabetic group(group C) ,8 in each. Rats in group C were treated with probucol for one month [500 mg/(kg/d) ,twice per day]. High-fat and high-sugar diets with a low dose injection of streptozotocin were performed in rats to establish type 2 diabetic models. The methods of glucose oxidase,enzymatic end-point and radioimmunoassay were repeatedly used to test the levels of fasting blood glucose(FBG) ,postprandial blood glucose(PBG) ,triglyceride(TG) ,total cholesterol(T-ch) and fasting insulin(FINS) . Pancreatic tissues were homogenized to test the content of malondialdehyde(MDA) ,nitric oxide(NO) ,superoxide dismutase(SOD) and glutathione peroxidase(GSH-Px) . Immunohistochemical method was used to detect the insulin expression. Results Compared with rats in the group A,the levels of MDA,NO and FINS were higher,while the levels of SOD,GSH-Px and insulin expression were lower in the group B(all P0.05) . After treated with probucol,compared with the group B,the levels of MDA,NO were lower,while the levels of SOD,GSH-Px and insulin expression were higher in the group C(all P0.05) . Conclusion Probucol can preserve pancreatic islet against damage from oxidative stress and improve the endocrine function of islet cells in type 2 diabetic rats.

Key concepts: Endocrinology, Internal medicine, Probucol, Glutathione peroxidase, Malondialdehyde, Islet, Insulin, Oxidative stress

Related papers

Back to paper searchBrowse research topicsOriginal source
Intervention effect of probucol on islet function in type 2 diabetes rats — Research Paper | ScholarLens